Search clinical trials for: MVA.HIVconsv booster vaccine

Total 6733 results

University College, London
GlaxoSmithKline; Medical Research Council; University of Oxford

Completed

Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination (HIV-CORE003)

HIV

United Kingdom
University of Oxford

Completed

A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines

HIV

United Kingdom
Tan Tock Seng Hospital
KK Women's and Children's Hospital; Duke-NUS Graduate Medical School; A*Star

Recruiting

Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC] (PRIBIVAC)

COVID-19

Singapore
University of California, San Francisco

Active, not recruiting

The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19) (BOOSTED)

COVID-19 | Vaccine Reaction | COVID-19 Pandemic

United States
Universidad del Desarrollo
Pontificia Universidad Catolica de Chile; University of Chile; Ministry of Health...

Active, not recruiting

Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster (REFUERZO)

Covid19

Chile
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults (M&M)

HIV-1 Infection

United States
Laval University

Completed

Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.

Human Papillomavirus

Canada
Duke University
Washington University School of Medicine; University of Pittsburgh; Centers for... and other collaborators

Active, not recruiting

Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

COVID-19 | Influenza

United States
Frank Lieberman
Oncovir, Inc.

Completed

Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas

Malignant Glioma

United States
COL George Peoples, MD, FACS

Completed

Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer

Ovarian Cancer | Endometrial Cancer | Peritoneal Cancer | Fallopian Cancer

United States
University of Toronto
Canadian Institutes of Health Research (CIHR); University of Nairobi; Kenyan...

Unknown

Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine (KAVI-VZV-001)

Healthy

Kenya
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; Right to Care and other collaborators

Recruiting

Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. (Sisonke Boost)

SARS CoV 2 Infection

South Africa
Kirby Institute
Medical Research Future Fund; Seqirus Pty Ltd, Australia

Recruiting

Immunosuppression and COVID-19 Boosters

COVID-19

Australia
Oregon Health and Science University

Active, not recruiting

The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)

Rheumatic Diseases

United States
IrsiCaixa
Hospital Clinic of Barcelona; University of Oxford; Germans Trias i Pujol Hospital and other collaborators

Completed

Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals

HIV

Spain
GlaxoSmithKline

Completed

Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects

Herpes Zoster

Germany, Czechia, Sweden, Netherlands
Bavarian Nordic

Recruiting

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination

Chikungunya Virus Infection

United States
Wuhan BravoVax Co., Ltd.
Shanghai BravoBio Co., Ltd.

Not yet recruiting

Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)

Herpes Zoster | Shingles
U.S. Army Medical Research and Development Command

Completed

Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults (RVEc)

Ricin Poisoning

United States
Seoul National University Hospital

Recruiting

Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant Recipients (CoVaKT)

Renal Transplant | COVID-19 Vaccination

Korea, Republic of
H. Lundbeck A/S

Terminated

Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD

Alzheimer Disease

Finland, Sweden
National Institute of Allergy and Infectious Diseases...
Merck Sharp & Dohme LLC; Cooperative Clinical Trials in Pediatric Transplantation and other collaborators

Terminated

Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients

Kidney Transplant Recipients

United States
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation

Liver Transplantation | Hepatitis B

Taiwan
National Institute of Allergy and Infectious Diseases...
Gilead Sciences; University of Oxford

Recruiting

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

HIV-1-infection

United States, Brazil
Novavax

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. (COVID-19)

COVID-19

United States
Seventh Medical Center of PLA General Hospital

Active, not recruiting

Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.

COVID-19

China
Hoffmann-La Roche

Completed

A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

Canada, United States
Institute for Clinical and Experimental Medicine

Active, not recruiting

Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

COVID-19 | Kidney Diseases | Vaccine Adverse Reaction | Kidney Transplant; Complications | Rejection Acute Renal | Rejection Chronic Renal

Czechia
Merck Sharp & Dohme LLC

Completed

Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2)

Vaccine Response Impaired
Lahore General Hospital

Active, not recruiting

Booster Effect of mRNA Vaccine on Antibody Response for SARS-CoV-2 After Complete Vaccination With Sinos

Vaccine Reaction

Pakistan
HaEmek Medical Center, Israel

Unknown

Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients

Herpes Zoster

Israel
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster

Herpes Zoster

Russian Federation, Canada
Beijing Luzhu Biotechnology Co., Ltd.

Recruiting

A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine

Herpes Zoster | Vaccine-Preventable Diseases

China
University of Rochester
GlaxoSmithKline

Completed

Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors

Chronic Lymphocytic Leukemia (CLL) | Waldenstrom Macroglobulinemia (WM)

United States
GlaxoSmithKline

Completed

Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A

Herpes Zoster

United States
Barbara Ann Karmanos Cancer Institute

Completed

COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies

Multiple Myeloma | AL Amyloidosis | Chronic Lymphocytic Leukemia

United States
GlaxoSmithKline

Completed

Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age

Herpes Zoster | Herpes Zoster Vaccine

United States, Canada, Belgium
GlaxoSmithKline

Completed

Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects

Herpes Zoster

Germany, United States, United Kingdom
Merck Sharp & Dohme LLC

Completed

A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)

Herpes Zoster
McMaster University
Merck Sharp & Dohme LLC

Completed

Zoster Vaccine Response in the Frail Elderly

Immune System Diseases

Canada
University of Oxford
Medical Research Council

Terminated

Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART

HIV-1

United Kingdom
Albert Einstein College of Medicine
Pancreatic Cancer Action Network

Terminated

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

Pancreatic Cancer

United States
University of Alberta

Completed

Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation

Kidney Transplant

Canada
Queen Saovabha Memorial Institute

Recruiting

Immunological Tolerance After Frequent Rabies Booster Vaccinations

Rabies

Thailand
ModernaTX, Inc.

Active, not recruiting

An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)

COVID-19

United States
Novartis Vaccines

Completed

Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years

Pertussis | Whooping Cough | Tetanus | Diphtheria | Lockjaw

Belgium
Louis Stokes VA Medical Center
Duke University

Unknown

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

Shingles
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)

Prevention of : Herpes-Zoster
National Institute of Allergy and Infectious Diseases...

Unknown

Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults

HIV Infections

United States

Search clinical trials for: MVA.HIVconsv booster vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations